Press

MindMics featured in Fierce Medtech's 2022 Fierce 15
Anna Barnacka Anna Barnacka

MindMics featured in Fierce Medtech's 2022 Fierce 15

The Fierce 15 has made a point of spotlighting the most exciting startups in medtech—those not only challenging the limits of both the tech and healthcare industries but also making real progress toward their lofty goals.

Read More
Showing Promise in Detection of Aortic Stenosis and Hearing Heart Murmurs
Guest User Guest User

Showing Promise in Detection of Aortic Stenosis and Hearing Heart Murmurs

Cambridge, Massachusetts--(Newsfile Corp. - March 7, 2023) - MindMics, a leader of infrasonic based technology enabled in-ear earphones and hearables, announced today that its earbuds have shown promise in the detection of aortic stenosis, a condition that restricts blood flow through the heart's aortic valve…

Read More
From Black Holes to Better Health: How MindMics and a2 Collective Have Their Eyes on Your Ears
Guest User Guest User

From Black Holes to Better Health: How MindMics and a2 Collective Have Their Eyes on Your Ears

MindMics, a startup portfolio member of the AgeTech Collaborative™ (ATC), is laser-focused on revolutionizing the technology of wearable biofeedback devices. MindMics recently completed an agreement to run a program with the a2 Collective, a testbed and ATC participant dedicated to helping Americans live longer, better lives through the application of artificial intelligence and emerging technologies.

Read More
The best of CES 2022 awards
Guest User Guest User

The best of CES 2022 awards

Android Authority’s Best of CES Awards honors the most exciting new products from the sea of announcements at the world’s biggest trade show. Amongst the very best of CES 2022, MindMics is proud to win ‘Best wearable innovation.’

Read More
Heart Rhythm Society Meeting in Boston
Guest User Guest User

Heart Rhythm Society Meeting in Boston

Cambridge, MA, (Heart Rhythm Society meeting in Boston, July 30, 4:15 pm EST, 2021, ): MindMics, Inc. today reported results from the clinical trial of revolutionary earbuds that make use of a new technology -- in-ear infrasonic hemodynography (IH) - for the monitoring of cardiac arrhythmias, resulting in insights beyond those that have been possible with state-of-the-art ECG monitoring.

Read More